Toggle Nav
Close
  • Menu
  • Setting

Anti-oxLDL Antibody (Orticumab)

Catalog No.
F1449
Anti-oxLDL Antibody (Orticumab)
Grouped product items
SizePriceStock Qty
100ug
$96.00
Ship with 3-5 days
1mg
$288.00
Ship with 3-5 days
5mg
$749.00
Ship with 3-5 days
50mg
$2,516.00
Ship with 3-5 days
For scientific research use only and should not be used for diagnostic or medical purposes.

Tel: +1-832-696-8203

Email: [email protected]

Worldwide Distributors

Background

Orticumab (MLDL1278A) is a novel biopharmaceutical targeting oxidized or malondialdehyde-modified lipoproteins (LDLOrticumab specifically inhibits oxidized low-density lipoprotein (oxLDL). Orticumab is involved in regulating the autoimmune response to oxLDL and can improve atherosclerosis in animal models. Orticumab can also be used in studies to improve psoriasis.

Quality Control

Quality Control & DataSheet

View current batch:
 

M.Wt

145 kDa

Shipping

Dry ice

Cas No.

1314241-10-5

Storage

-80°C

Expiration Date

2 years

Form

Liquid

Concentration

See label

Reconstitution

For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.

Host

CHO

Alternative Names

Anti-oxLDL, RG7418, BI-204

Buffer System

100 mM Pro 20 mM Arg pH 5.0. No preservative!

Reactivity

Human

Conjugation

Unconjugated

Clonality

Monoclonal

Isotype

IgG1

Application

ELISA, FACS, Kinetics, Functional assay, Animal Model

Target

oxLDL

Note

Please avoid freeze-thaw cycles.